We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+11.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$22.4B
AUM Growth
+$5.13B
(+30%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
58.5%
Holding
2,355
New
540
Increased
504
Reduced
836
Closed
452
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$98.9M |
| 2 |
NVIDIA
NVDA
|
+$92.7M |
| 3 |
Microsoft
MSFT
|
+$59.2M |
| 4 |
Apple
AAPL
|
+$46.8M |
| 5 |
Tesla
TSLA
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Large Cap Deep Quarterly Laddered ETF
IVVB
|
+$461M |
| 2 |
Palantir
PLTR
|
+$138M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$117M |
| 4 |
Applovin
APP
|
+$92.3M |
| 5 |
Amazon
AMZN
|
+$78.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.39% |
| 2 | Financials | 2.87% |
| 3 | Communication Services | 2.77% |
| 4 | Industrials | 2.15% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Vera Therapeutics
VERA
$2.17B
| $557K | ﹤0.01% |
+19,181
| New | +$444K |
|
1227
Paychex
PAYX
$43.1B
| $556K | ﹤0.01% |
4,390
-10,018
| -70% | -$1.39M |
|
1228
Paymentus
PAY
$5.11B
| $556K | ﹤0.01% |
+18,157
| New | +$600K |
|
1229
Trimble
TRMB
$13.5B
| $554K | ﹤0.01% |
6,783
-39,524
| -85% | -$3.22M |
|
1230
Kulicke & Soffa
KLIC
$4.76B
| $554K | ﹤0.01% |
+13,625
| New | +$505K |
|
|
SEM
1231
DELISTED
Select Medical
SEM
| $553K | ﹤0.01% |
+43,071
| New | +$574K |
|
1232
Winnebago Industries
WGO
$927M
| $552K | ﹤0.01% |
16,515
-24,008
| -59% | -$792K |
|
1233
Genworth Financial
GNW
$3.7B
| $552K | ﹤0.01% |
62,042
-276,390
| -82% | -$2.28M |
|
1234
Colliers International
CIGI
$5.3B
| $551K | ﹤0.01% |
+3,523
| New | +$542K |
|
|
MRP
1235
Millrose Properties Inc
MRP
$4.94B
| $550K | ﹤0.01% |
+16,370
| New | +$529K |
|
1236
Astronics
ATRO
$3.7B
| $550K | ﹤0.01% |
+14,464
| New | +$440K |
|
|
WCC
1237
WESCO International
WCC
$17.8B
| $549K | ﹤0.01% |
2,598
-19,443
| -88% | -$4.08M |
|
1238
Mercury Insurance
MCY
$5.86B
| $548K | ﹤0.01% |
6,469
+3,383
| +110% | +$250K |
|
1239
Cytokinetics
CYTK
$10.6B
| $548K | ﹤0.01% |
+9,974
| New | +$411K |
|
1240
Mueller Water Products
MWA
$4.09B
| $548K | ﹤0.01% |
21,456
-52,680
| -71% | -$1.34M |
|
1241
QuinStreet
QNST
$1.2B
| $547K | ﹤0.01% |
35,379
-5,186
| -13% | -$82.3K |
|
1242
Supernus Pharmaceuticals
SUPN
$2.73B
| $547K | ﹤0.01% |
11,447
-24,658
| -68% | -$993K |
|
1243
Huntington Ingalls Industries
HII
$12.9B
| $545K | ﹤0.01% |
1,894
-15,356
| -89% | -$4.09M |
|
1244
Neurocrine Biosciences
NBIX
$16.5B
| $545K | ﹤0.01% |
3,884
-11,752
| -75% | -$1.59M |
|
1245
Liberty Energy
LBRT
$3.51B
| $544K | ﹤0.01% |
44,061
+7,737
| +21% | +$89.5K |
|
1246
Sally Beauty Holdings
SBH
$1.58B
| $543K | ﹤0.01% |
33,374
-75,420
| -69% | -$948K |
|
|
EXK
1247
Endeavour Silver
EXK
$3.14B
| $543K | ﹤0.01% |
+69,282
| New | +$409K |
|
1248
Reinsurance Group of America
RGA
$16B
| $543K | ﹤0.01% |
2,827
-3,360
| -54% | -$643K |
|
1249
Toll Brothers
TOL
$14.3B
| $542K | ﹤0.01% |
3,926
-7,232
| -65% | -$944K |
|
|
AD
1250
Array Digital Infrastructure
AD
$3.01B
| $542K | ﹤0.01% |
10,840
+5,581
| +106% | +$347K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
DWM
HTC
BCI
Brevan Howard Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Brevan Howard Capital Management held 2,355 positions worth $22.4B, up 30% from $17.3B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Brevan Howard Capital Management deployed $1.14B of net new capital in Q3 2025, opening 540 new positions and adding to 504 existing holdings. Its largest new stake was SPDR Gold Trust: 93,000 shares worth $33.1M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Palantir, an estimated $138M trimmed.
- Brevan Howard Capital Management's largest Q3 2025 buy was SPDR Gold Trust: 93,000 shares worth $33.1M.
- Brevan Howard Capital Management added most to Meta Platforms (Facebook) in Q3 2025, an estimated $98.9M increase.
- Brevan Howard Capital Management's biggest Q3 2025 reduction was Palantir, cutting an estimated $138M.
- Brevan Howard Capital Management fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $461M.
- Brevan Howard Capital Management's ten largest holdings make up 59% of its $22.4B portfolio in Q3 2025.
- Brevan Howard Capital Management opened 540 new positions and closed 452 in Q3 2025.
- Brevan Howard Capital Management's portfolio value rose 30% quarter-over-quarter to $22.4B.
Based on Brevan Howard Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.